Changes

no edit summary
Line 1: Line 1:  +
==Acknowledgement==
 +
This list is based on the [http://www.mayomedicallaboratories.com/articles/features/hem-cyto/index.html '''Mayo Clinic Hematologic Cytogenetics Reference Sheet, November 2012'''].
 +
 
__TOC__
 
__TOC__
   Line 12: Line 15:  
|[[Translocation der(1)t(1;1)(p36;q21)|der(1)t(1;1)(p36;q21)]]
 
|[[Translocation der(1)t(1;1)(p36;q21)|der(1)t(1;1)(p36;q21)]]
 
|[[NHL]]
 
|[[NHL]]
 +
|
 
|-
 
|-
 
|[[Translocation t(1;3)(p36;q21)|t(1;3)(p36;q21)]]
 
|[[Translocation t(1;3)(p36;q21)|t(1;3)(p36;q21)]]
|[[MDS]],[[ AML]]
+
|[[MDS]],[[AML]]
 
|[[PRDM16(MEL1)-RPN1]]
 
|[[PRDM16(MEL1)-RPN1]]
 
|-
 
|-
|[[t(1;3;5)(p36;p21;q33) ]]
+
|[[t(1;3;5)(p36;p21;q33)]]
 
|[[CEL]]
 
|[[CEL]]
 
|[[WDR48-PDGFRB]]
 
|[[WDR48-PDGFRB]]
Line 26: Line 30:  
|-
 
|-
 
|[[t(1;5)(q22;q33)]]
 
|[[t(1;5)(q22;q33)]]
|[[MPD with eosinophilia]],[[ CEL]],[[ B-ALL]]
+
|[[MPD]],[[ CEL]],[[ B-ALL]]
 
|[[PDE4DIP-PDGFRB]]
 
|[[PDE4DIP-PDGFRB]]
 
|-
 
|-
 
|[[der(1;7)(q10;p10)]]
 
|[[der(1;7)(q10;p10)]]
|[[MDS]],[[ AML]],[[ MPD]]
+
|[[MDS]],[[AML]],[[ MPD]]
 +
|
 
|-
 
|-
 
|[[t(1;8)(p13;q24.1)]]  
 
|[[t(1;8)(p13;q24.1)]]  
|Missing
+
|
| [[MYC(C-MYC)]]
+
|[[MYC]]
 
|-
 
|-
 
|[[t(1;14)(q21;q32)]]
 
|[[t(1;14)(q21;q32)]]
|[[B-ALL]],[[ NHL]]
+
|[[B-ALL]],[[NHL]]
|[[BCL9-IGH]],[[ FCGR2B-IGH]],[[ FCRL4-IGH]],[[ MUC1/IGH]]
+
|[[IGH-BCL9]],[[IGH-FCGR2B]],[[IGH-FCRL4]],[[IGH-MUC1]]
 
|-
 
|-
 
|[[t(1;19)(q23;p13.3) ]]
 
|[[t(1;19)(q23;p13.3) ]]
 
|[[B-ALL]]
 
|[[B-ALL]]
|[[PBX1-TCF3(E2A)]]
+
|[[TCF3(E2A)-PBX1]]
 +
|-
 +
|[[Translocation der(16)t(1;16)(q21;q11.2)|der(16)t(1;16)(q21;q11.2)]]
 +
|
 +
|
 
|-
 
|-
 
|[[der(1;22)(q10;p10)]]
 
|[[der(1;22)(q10;p10)]]
 +
|
 +
|
 
|-
 
|-
 
|[[t(2;5)(p23;q35)]]
 
|[[t(2;5)(p23;q35)]]
|[[ALCL]],[[ NHL]]
+
|[[ALCL]],[[NHL]]
|[[ALK-NPM1]]
+
|[[NPM1-ALK]]
 
|-
 
|-
 
|[[t(2;8)(p12;q24.1)]]
 
|[[t(2;8)(p12;q24.1)]]
|[[BL]],[[ B-ALL]],[[ NHL ]]
+
|[[BL]],[[ B-ALL]],[[NHL]]
|[[MYC(C-MYC)]]
+
|[[MYC]]
 
|-
 
|-
 
|[[t(2;11)(p21;q23)]]
 
|[[t(2;11)(p21;q23)]]
|[[MDS]],[[ AML]],[[ B-ALL]]
+
|[[MDS]],[[AML]],[[B-ALL]]
|[[MLL]]
+
|[[KMT2A]]
 
|-
 
|-
 
|[[t(2;14)(p15;q32)]]
 
|[[t(2;14)(p15;q32)]]
|[[CLL]],[[ NHL]],[[ B-ALL]],[[ T-ALL]],[[ AML]]
+
|[[CLL]],[[ NHL]],[[ B-ALL]],[[ T-ALL]],[[AML]]
 +
|
 
|-
 
|-
|[[t(3;3)(q21;q26.2) ]]
+
|[[Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2)|t(3;3)(q21;q26.2)]]
|[[MDS]],[[ AML]]
+
|[[MDS]],[[AML]]
 
|[[RPN1-MECOM(EVI1)]]
 
|[[RPN1-MECOM(EVI1)]]
 
|-
 
|-
 
|[[t(3;5)(p21-25;q32-35)]]
 
|[[t(3;5)(p21-25;q32-35)]]
 
|[[MPD]]
 
|[[MPD]]
|[[GOLGA4-PDGFRB ]]
+
|[[GOLGA4-PDGFRB]]
 
|-
 
|-
 
|[[t(3;21)(q26.2;q22)]]
 
|[[t(3;21)(q26.2;q22)]]
Line 75: Line 87:  
|[[t(4;11)(q21;q23)]]
 
|[[t(4;11)(q21;q23)]]
 
|[[B-ALL]],[[ T-ALL]]
 
|[[B-ALL]],[[ T-ALL]]
|[[AFF1(AF4)-MLL]]
+
|[[KMT2A-AFF1]]
 
|-
 
|-
 
|[[t(4;14)(p16.3;q32)]]
 
|[[t(4;14)(p16.3;q32)]]
 
|[[MM]]
 
|[[MM]]
|[[ FGFR3-IGH]]
+
|[[IGH-FGFR3]]
 
|-
 
|-
 
|[[t(4;22)(q12;q11)]]
 
|[[t(4;22)(q12;q11)]]
 
|[[atypical MPD]]
 
|[[atypical MPD]]
|[[ PDGFRA -BCR]]
+
|[[BCR-PDGFRA]]
 
|-
 
|-
 
|[[t(4;5;5)(q23;q31;q33)]]
 
|[[t(4;5;5)(q23;q31;q33)]]
|[[chronic basophilic leukemia]]
+
|[[Chronic Basophilic Leukemia]]
 
|[[PRKG2-PDGFRB]]
 
|[[PRKG2-PDGFRB]]
 
|-
 
|-
Line 102: Line 114:  
|-
 
|-
 
|[[t(5;12)(q33;q24)]]
 
|[[t(5;12)(q33;q24)]]
|[[MPD with eosinophilia  ]]
+
|[[MPD]]
 
|[[GIT2-PDGFRB]]
 
|[[GIT2-PDGFRB]]
 
|-
 
|-
 
|[[t(5;12)(q33;p13)]]
 
|[[t(5;12)(q33;p13)]]
|[[CMML]],[[ MDS]],[[ MPD]]
+
|[[CMML]],[[MDS]],[[MPD]]
 
|[[ETV6(TEL)-PDGFRB]]
 
|[[ETV6(TEL)-PDGFRB]]
 
|-
 
|-
 
|[[t(5;14)(q33;q24)]]
 
|[[t(5;14)(q33;q24)]]
|[[MPD]],[[ atypical MPD]]
+
|[[MPD]],[[MPD]]
 
|[[NIN-PDGFRB]]
 
|[[NIN-PDGFRB]]
 
|-
 
|-
 
|[[t(5;14)(q33;q32)]]
 
|[[t(5;14)(q33;q32)]]
 +
|
 
|[[CCDC88C(KIAA1509)-PDGFRB]]
 
|[[CCDC88C(KIAA1509)-PDGFRB]]
 
|-
 
|-
 
|[[t(5;15)(q33;q22)]]
 
|[[t(5;15)(q33;q22)]]
|[[CMML atypical MPD]]
+
|[[CMML]],[[MPD]]
 
|[[TP53BP1-PDGFRB]]
 
|[[TP53BP1-PDGFRB]]
 
|-
 
|-
Line 129: Line 142:  
|-
 
|-
 
|[[der(5;17)(p10;q10)]]
 
|[[der(5;17)(p10;q10)]]
|[[MDS]],[[ AML]]
+
|[[MDS]],[[AML]]
 
|[[NPM1(NPM)-RARA]]
 
|[[NPM1(NPM)-RARA]]
 
|-
 
|-
Line 137: Line 150:  
|-
 
|-
 
|[[t(5;17)(q33;p13)]]
 
|[[t(5;17)(q33;p13)]]
|[[CMML]],[[ atypical MPD]]
+
|[[CMML]],[[MPD]]
 
|[[RABEP1-PDGFRB ]]
 
|[[RABEP1-PDGFRB ]]
 
|-
 
|-
 
|[[der(6)t(1;6)(q21;p21.3)]]
 
|[[der(6)t(1;6)(q21;p21.3)]]
 
|[[PMF]]
 
|[[PMF]]
 +
|
 
|-
 
|-
 
|[[t(6;9)(p23;q34) ]]
 
|[[t(6;9)(p23;q34) ]]
|[[MDS]],[[ AML]]
+
|[[MDS]],[[AML]]
 
|[[DEK-NUP214 (CAN)]]
 
|[[DEK-NUP214 (CAN)]]
 
|-
 
|-
 
|[[t(6;11)(q27;q23) ]]
 
|[[t(6;11)(q27;q23) ]]
|[[AML]],[[ t-AML]],[[ T-ALL]]
+
|[[AML]],[[ t-AML]],[[T-ALL]]
|[[MLLT4(AF6)-MLL]]
+
|[[KMT2A-MLLT4]]
 
|-
 
|-
 
|[[t(7;11)(p15;p15)]]
 
|[[t(7;11)(p15;p15)]]
Line 157: Line 171:  
|[[t(8;14)(q24.1;q32) ]]
 
|[[t(8;14)(q24.1;q32) ]]
 
|[[BL]],[[ B-ALL]],[[ NHL]]
 
|[[BL]],[[ B-ALL]],[[ NHL]]
|[[MYC(C-MYC)- IGH]]
+
|[[IGH-MYC]]
 
|-
 
|-
|[[t(8;16)(p11.2;p13.3) A]]
+
|[[t(8;16)(p11.2;p13.3)]]
|[[AML M4]],[[ M5a]],[[ M5b]],[[ t-MDS]]
+
|[[AML]],[[t-MDS]]
 
|[[KAT6A(MYST3)-CREBBP(CBP)]]
 
|[[KAT6A(MYST3)-CREBBP(CBP)]]
 
|-
 
|-
 
|[[t(8;21)(q22;q22) A ]]
 
|[[t(8;21)(q22;q22) A ]]
|[[AML M2 mostly]],[[ rarely M1]],[[ M4]]
+
|[[AML]]
 
|[[RUNX1(AML)-RUNX1T1(ETO)]]
 
|[[RUNX1(AML)-RUNX1T1(ETO)]]
 
|-
 
|-
 
|[[t(8;22)(q24.1;q11.2) ]]
 
|[[t(8;22)(q24.1;q11.2) ]]
|[[BL]],[[ B-ALL]],[[ NHL]],[[ MM]]
+
|[[BL]],[[ B-ALL]],[[NHL]],[[ MM]]
|[[MYC(C-MYC)-IGL(IGL)]]
+
|[[IGL-MYC]]
 
|-
 
|-
 
|[[add(9)(p24)]]
 
|[[add(9)(p24)]]
 +
|
 
|[[JAK2]]
 
|[[JAK2]]
 
|-
 
|-
 
|[[t(9;11)(p22;q23)]]
 
|[[t(9;11)(p22;q23)]]
|[[AML mostly M5]],[[ M4]],[[ B-ALL]]
+
|[[AML]],[[B-ALL]]
|[[MLLT3(AF9)-MLL]]
+
|[[KMT2A-MLLT3]]
 
|-
 
|-
 
|[[t(9;14)(p13;q32)]]
 
|[[t(9;14)(p13;q32)]]
|[[MM]],[[ CLL]],[[ DLBCL]],[[ FL]],[[ MCL splenic MZL]]
+
|[[MM]],[[CLL]],[[DLBCL]],[[FL]],[[MCL splenic MZL]]
 
|[[PAX5-IGH]]
 
|[[PAX5-IGH]]
 
|-
 
|-
|[[t(9;22)(q34;q11.2) A B ]]
+
|[[t(9;22)(q34;q11.2)]]
|[[CML]],[[ B-ALL]],[[ T-ALL]]
+
|[[CML]],[[ B-ALL]],[[T-ALL]]
 
|[[ABL1(ABL)-BCR]]
 
|[[ABL1(ABL)-BCR]]
 
|-
 
|-
|[[t(11;14)(q13;q32) A ]]
+
|[[t(11;14)(q13;q32)]]
 
|[[MCL]],[[ MM]]
 
|[[MCL]],[[ MM]]
|[[CCND1(BCL1)- IGH]]
+
|[[IGH-CCND1]]
 
|-
 
|-
 
|[[t(11;14)(q23;q32)]]
 
|[[t(11;14)(q23;q32)]]
|[[t-AML]]
+
|[[AML]]
|[[MLL-KIAA0284]]
+
|[[KMT2A-KIAA0284]]
 
|-
 
|-
 
|[[t(11;16)(q23;p13.3)]]
 
|[[t(11;16)(q23;p13.3)]]
Line 206: Line 221:  
|[[BIRC3(API2)-MALT1]]
 
|[[BIRC3(API2)-MALT1]]
 
|-
 
|-
|[[t(11;19)(q23;p13.1) ]]
+
|[[t(11;19)(q23;p13.1)]]
 
|[[AML]]
 
|[[AML]]
|[[MLL-ELL]]
+
|[[KMT2A-ELL]]
 
|-
 
|-
|[[t(11;19)(q23;p13.3) ]]
+
|[[t(11;19)(q23;p13.3)]]
|[[B-ALL]],[[ AML]],[[ T-ALL]]
+
|[[B-ALL]],[[AML]],[[T-ALL]]
|[[MLL-MLLT1(ENL)]]
+
|[[KMT2A-MLLT1]]
 
|-
 
|-
 
|[[t(14;16)(q32;q23)]]
 
|[[t(14;16)(q32;q23)]]
Line 218: Line 233:  
|[[IGH-MAF]]
 
|[[IGH-MAF]]
 
|-
 
|-
|[[t(14;18)(q32;q21) ]]
+
|[[t(14;18)(q32;q21)]]
|[[BL]],[[ DLBCL]],[[ FL]],[[ CLL]]
+
|[[BL]],[[DLBCL]],[[FL]],[[CLL]]
 
|[[IGH-BCL2]]
 
|[[IGH-BCL2]]
 
|-
 
|-
 
|[[t(14;19)(q32;q13.3)]]
 
|[[t(14;19)(q32;q13.3)]]
|[[CLL]],[[ DLBCL]],[[ MCL]],[[ MZL]],[[ SLVL]]
+
|[[CLL]],[[DLBCL]],[[MCL]],[[MZL]],[[SLVL]]
 +
|[[IGH-BCL3]]
 
|-
 
|-
 
|[[t(14;19)(q32;q13)]]
 
|[[t(14;19)(q32;q13)]]
Line 247: Line 263:  
|[[der(Y)t(Y;1)(q12;q12) ]]
 
|[[der(Y)t(Y;1)(q12;q12) ]]
 
|[[MDS]]
 
|[[MDS]]
 
+
|
 
|}
 
|}
   Line 259: Line 275:  
|'''GENES'''
 
|'''GENES'''
 
|-
 
|-
|[[inv(3)(q21q26.2) ]]
+
|[[Translocation t(3;3)(q21;q26.2) and Inversion inv(3)(q21q26.2)|inv(3)(q21q26.2)]]
 
|[[MDS]],[[ AML]]
 
|[[MDS]],[[ AML]]
 
|[[RPN1-MECOM(EVI1)]]
 
|[[RPN1-MECOM(EVI1)]]
Line 273: Line 289:  
|[[inv(16)(p13.1q22)]]
 
|[[inv(16)(p13.1q22)]]
 
|[[AML M4Eo]]
 
|[[AML M4Eo]]
|[[MYH11]],[[ CBFB]]
+
|[[MYH11-CBFB]]
 
|}
 
|}
   Line 286: Line 302:  
|-
 
|-
 
|[[dup(1)(q11q44) ]]
 
|[[dup(1)(q11q44) ]]
 +
|
 +
|
 
|-
 
|-
 
|[[dup(1)(q21q32) ]]
 
|[[dup(1)(q21q32) ]]
 
|[[B-ALL]],[[ NHL]]
 
|[[B-ALL]],[[ NHL]]
 +
|
 
|-
 
|-
 
|[[dup(1)(q21q42)]]
 
|[[dup(1)(q21q42)]]
 +
|
 +
|
 
|-
 
|-
 
|[[dup(1)(q23q32)]]
 
|[[dup(1)(q23q32)]]
 +
|
 +
|
 
|-
 
|-
 
|[[dup(1)(q23q42)]]
 
|[[dup(1)(q23q42)]]
 
|[[NHL ]]
 
|[[NHL ]]
 +
|
 
|-
 
|-
 
|[[dup(11)(q13q25)]]
 
|[[dup(11)(q13q25)]]
Line 302: Line 326:  
|-
 
|-
 
|[[dup(12)(q13q22)]]
 
|[[dup(12)(q13q22)]]
 +
|
 +
|
 
|}
 
|}
      
==Isochromsomes==
 
==Isochromsomes==
Line 316: Line 341:  
|[[i(1)(q10)]]
 
|[[i(1)(q10)]]
 
|[[NHL]]
 
|[[NHL]]
 +
|
 
|-
 
|-
 
|[[i(3)(q10)]]
 
|[[i(3)(q10)]]
 
|[[NHL]]
 
|[[NHL]]
 +
|
 
|-
 
|-
 
|[[i(7)(q10) ]]
 
|[[i(7)(q10) ]]
 
|[[T-cell lymphoma]]
 
|[[T-cell lymphoma]]
 +
|
 
|-
 
|-
 
|[[i(8)(q10)]]
 
|[[i(8)(q10)]]
 
|[[T-ALL]],[[ AML]],[[ B-ALL]]
 
|[[T-ALL]],[[ AML]],[[ B-ALL]]
 +
|
 
|-
 
|-
 
|[[i(11)(q10) ]]
 
|[[i(11)(q10) ]]
|[[AML M2]],[[AML M4]],[[ MDS]]
+
|[[AML]],[[AML]],[[ MDS]]
 +
|
 
|-
 
|-
 
|[[i(17)(q10)]]
 
|[[i(17)(q10)]]
|[[MDS]],[[ MPD]],[[ AML]],[[ CML]],[[ B-ALL]],[[ CLL]],[[ Hodgkin and NHL]]
+
|[[MDS]],[[ MPD]],[[ AML]],[[ CML]],[[ B-ALL]],[[CLL]],[[ Hodgkin and NHL]]
 +
|
 
|-
 
|-
 
|[[i(21)(q10)]]
 
|[[i(21)(q10)]]
|[[B-ALL]],[[ MDS]],[[ NHL]],[[ AML]],[[ CMML]]
+
|[[B-ALL]],[[ MDS]],[[ NHL]],[[AML]],[[ CMML]]
|[na]
+
|
 
|-
 
|-
 
|[[idic(X)(q13)]]
 
|[[idic(X)(q13)]]
|[[AML M1]],[[ M2]],[[ M4]],[[ MDS]],[[ RARS]]
+
|[[AML]],[[MDS]],[[RARS]]
 
|[[XIST]]
 
|[[XIST]]
 
|}
 
|}
Line 354: Line 385:  
|[[ETV6 (TEL)-RUNX1(AML1)]]
 
|[[ETV6 (TEL)-RUNX1(AML1)]]
 
|-
 
|-
|[[t(X;14)]]
+
|[[t(X;14) and t(Y;14)]]
|[[B-ALL]]
  −
|[[CRLF2-IGH]]
  −
|-
  −
|[[t(Y;14)]]
   
|[[B-ALL]]
 
|[[B-ALL]]
|[[CRLF2-IGH]]
+
|[[T(X;14) and t(Y;14)|IGH-CRLF2]]
 
|-
 
|-
 
|[[t(5;14)(q35;q32)]]
 
|[[t(5;14)(q35;q32)]]
Line 367: Line 394:  
|-
 
|-
 
|[[del(1)(p32p32)]]
 
|[[del(1)(p32p32)]]
|[[B-ALL]]
+
|[[T-ALL]]
|[[TAL1-STIL]]
+
|[[SIL(STIL)-TAL1]]
 
|}
 
|}
      
==Deletions==
 
==Deletions==
Line 383: Line 409:  
|[[del(1)(p32p36)]]
 
|[[del(1)(p32p36)]]
 
|[[NHL]],[[ MM]]
 
|[[NHL]],[[ MM]]
 +
|
 
|-
 
|-
 
|[[del(1)(p32-34p36.1)]]
 
|[[del(1)(p32-34p36.1)]]
 +
|
 +
|
 
|-
 
|-
 
|[[del(1)(p36.1)]]
 
|[[del(1)(p36.1)]]
Line 391: Line 420:  
|-
 
|-
 
|[[del(3)(p13p21)]]
 
|[[del(3)(p13p21)]]
 
+
|
 +
|
 
|-
 
|-
 
|[[del(3)(q21)]]
 
|[[del(3)(q21)]]
 
|[[B-ALL]],[[ AML]],[[ NHL]]
 
|[[B-ALL]],[[ AML]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(5)(q13q33) ]]
 
|[[del(5)(q13q33) ]]
Line 418: Line 448:  
|-
 
|-
 
|[[del(6)(q13q23)]]
 
|[[del(6)(q13q23)]]
|[[CLL]],[[ atypical CLL]],[[ FL]],[[ MCL]],[[ T-NHL]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]]
+
|[[CLL]],[[ atypical CLL]],[[FL]],[[MCL]],[[T-NHL]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[MM]]
 +
|
 
|-
 
|-
 
|[[del(6)(q15q21)]]
 
|[[del(6)(q15q21)]]
 
+
|
 +
|
 
|-
 
|-
 
|[[del(6)(q21)]]
 
|[[del(6)(q21)]]
 
|[[CLL]],[[ atypical CLL]],[[ AML]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]]
 
|[[CLL]],[[ atypical CLL]],[[ AML]],[[ childhood B-ALL]],[[ childhood T-ALL]],[[ adult ALL]],[[ MM]]
 +
|
 
|-
 
|-
 
|[[del(7)(p15)]]
 
|[[del(7)(p15)]]
 +
|
 +
|
 
|-
 
|-
 
|[[del(7)(p13) ]]
 
|[[del(7)(p13) ]]
 
|[[AML]],[[ NHL]]
 
|[[AML]],[[ NHL]]
 +
|
 
|-
 
|-
 
|[[del(7)(p13p15)]]
 
|[[del(7)(p13p15)]]
 
+
|
 +
|
 
|-
 
|-
 
|[[del(7)(p11.2)]]
 
|[[del(7)(p11.2)]]
 
|[[B-ALL]],[[ AML]],[[ MDS]]
 
|[[B-ALL]],[[ AML]],[[ MDS]]
 +
|
 
|-
 
|-
 
|[[del(7)(q11.2)]]
 
|[[del(7)(q11.2)]]
 
|[[B-ALL]],[[ AML]],[[ MDS]]
 
|[[B-ALL]],[[ AML]],[[ MDS]]
 
+
|
 
|-
 
|-
 
|[[del(7)(q22q34)]]
 
|[[del(7)(q22q34)]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(7)(q32q34)]]
 
|[[del(7)(q32q34)]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(7)(q32)]]
 
|[[del(7)(q32)]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 
|[[AML]],[[ MDS]],[[ NHL]]
 +
|
 
|-
 
|-
 
|[[del(8)(p21)]]
 
|[[del(8)(p21)]]
 +
|
 +
|
 
|-
 
|-
 
|[[del(8)(q22)]]
 
|[[del(8)(q22)]]
 +
|
 +
|
 
|-
 
|-
 
|[[del(9)(p13)]]
 
|[[del(9)(p13)]]
 
|[[B-ALL]],[[ NHL]],[[ pediatric B-ALL ]]
 
|[[B-ALL]],[[ NHL]],[[ pediatric B-ALL ]]
 
+
|
 
|-
 
|-
 
|[[del(9)(p13p22)]]
 
|[[del(9)(p13p22)]]
 
|[[B-ALL]]
 
|[[B-ALL]]
 +
|
 
|-
 
|-
 
|[[del(9)(p21)]]
 
|[[del(9)(p21)]]
 
|[[B-ALL]],[[ AML]],[[ NHL]]
 
|[[B-ALL]],[[ AML]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(9)(p22)]]
 
|[[del(9)(p22)]]
 
|[[B-ALL]]
 
|[[B-ALL]]
 
+
|
 
|-
 
|-
 
|[[del(9)(q13)]]
 
|[[del(9)(q13)]]
 
|[[AML M1]],[[ M2]],[[ M4]],[[ M6]]
 
|[[AML M1]],[[ M2]],[[ M4]],[[ M6]]
 
+
|
 
|-
 
|-
 
|[[del(9)(q13q22)]]
 
|[[del(9)(q13q22)]]
 
|[[AML]],[[ MDS]]
 
|[[AML]],[[ MDS]]
 
+
|
 
|-
 
|-
 
|[[del(10)(q24)]]
 
|[[del(10)(q24)]]
 
+
|
 +
|
 
|-
 
|-
 
|[[del(11)(p11.2)]]
 
|[[del(11)(p11.2)]]
 
|[[NHL]]
 
|[[NHL]]
 
+
|
 
|-
 
|-
 
|[[del(11)(p12p13)]]
 
|[[del(11)(p12p13)]]
Line 491: Line 536:  
|-
 
|-
 
|[[del(11)(q13)]]  
 
|[[del(11)(q13)]]  
|Missing
+
|
 +
|
 
|-
 
|-
 
|[[del(11)(q13q21)]]  
 
|[[del(11)(q13q21)]]  
|Missing
+
|
 +
|
 
|-
 
|-
 
|[[del(11)(q13q23)]]
 
|[[del(11)(q13q23)]]
Line 514: Line 561:  
|[[del(13)(q12q14)]]
 
|[[del(13)(q12q14)]]
 
|[[AML]],[[ AMM]],[[ MDS]],[[ NHL]]
 
|[[AML]],[[ AMM]],[[ MDS]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(13)(q12q22)]]
 
|[[del(13)(q12q22)]]
 
|[[AML]],[[ PMF]],[[ CLL]],[[ MM]],[[ MDS]],[[ NHL]]
 
|[[AML]],[[ PMF]],[[ CLL]],[[ MM]],[[ MDS]],[[ NHL]]
 +
|
 
|-
 
|-
 
|[[del(14)(q24) ]]
 
|[[del(14)(q24) ]]
 
|[[NHL]]
 
|[[NHL]]
 +
|
 
|-
 
|-
 
|[[del(16)(q22)]]
 
|[[del(16)(q22)]]
|[[AML]],[[ AML-M4Eo]],[[ NHL]]
+
|[[AML]],[[AML-M4Eo]],[[ NHL]]
 
+
|
 
|-
 
|-
 
|[[del(17)(p11.2)]]
 
|[[del(17)(p11.2)]]
Line 532: Line 581:  
|[[del(18)(q21)]]
 
|[[del(18)(q21)]]
 
|[[AML]],[[ NHL]]
 
|[[AML]],[[ NHL]]
 
+
|
 +
|-
 +
|[[del(20)(q11.2q13.1)]]
 +
|
 +
|
 
|-
 
|-
|[[del(20)(q11.2q13.1)
+
|[[del(20)(q11.2q13.3)]]
del(20)(q11.2q13.3)]]
+
|[[AML]],[[MDS]],[[MPD]]
|[[AML]],[[ MDS]],[[ MPD]]
+
|
 
|-
 
|-
 
|[[ider(20)(p11.1)del(20)(q11.2q13.3)]]
 
|[[ider(20)(p11.1)del(20)(q11.2q13.3)]]
 
|[[AML]],[[ MDS]],[[ MPD]]
 
|[[AML]],[[ MDS]],[[ MPD]]
|[["
+
|
 
|-
 
|-
 
|[[del(X)(q24)]]
 
|[[del(X)(q24)]]
 
|[[NHL]]
 
|[[NHL]]
 
+
|
 
|}
 
|}
   Line 554: Line 607:  
|'''ANOMALY'''
 
|'''ANOMALY'''
 
|'''ASSOCIATED DISORDERS with FISH test'''
 
|'''ASSOCIATED DISORDERS with FISH test'''
|'''GENES'''
   
|-
 
|-
 
|[[+3]]
 
|[[+3]]
Line 584: Line 636:  
|-
 
|-
 
|[[+15]]
 
|[[+15]]
|Age related when sole anomaly or with -Y
+
|[[Age Related]] when sole anomaly or with [[-Y]]
 
|-
 
|-
 
|[[+19]]
 
|[[+19]]
Line 595: Line 647:  
|[[AML-M4eo]]
 
|[[AML-M4eo]]
 
|-
 
|-
|[[-7 A B]]
+
|[[-7]]
|[[MDS]],[[ RAEB/RAEB±T]],[[ CMML]],[[ J-CML]],[[ AML most often M4 or M6.]]
+
|[[MDS]],[[RAEB/RAEB±T]],[[CMML]],[[J-CML]],[[AML most often M4 or M6.]]
 
|-
 
|-
 
|[[-Y ]]
 
|[[-Y ]]
|age related when sole anomaly
+
|[[Age Related]] when sole anomaly
    
|}
 
|}
Line 622: Line 674:  
|[[t(8;14)(q11;q32)]]
 
|[[t(8;14)(q11;q32)]]
 
|[[B-ALL]]
 
|[[B-ALL]]
|[[CEBPD-IGH]]
+
|[[IGH-CEBPB]]
 
|-
 
|-
 
|[[i(9)(q10)/idic(9)(q10)]]
 
|[[i(9)(q10)/idic(9)(q10)]]
 
|[[B-ALL]]
 
|[[B-ALL]]
 +
|
 
|-
 
|-
 
|[[dic(9;12)(p11;p11.2)]]
 
|[[dic(9;12)(p11;p11.2)]]
 
|[[B-ALL]]
 
|[[B-ALL]]
 +
|
 
|-
 
|-
 
|[[dic(9;20)(p11;q11)]]
 
|[[dic(9;20)(p11;q11)]]
Line 665: Line 719:  
|[[T-ALL]]
 
|[[T-ALL]]
 
|[[LMO2(Rhom2)-TRA]]
 
|[[LMO2(Rhom2)-TRA]]
   
|}
 
|}
==Acknowledgements==
  −
This list is based on the Mayo clinic Hematologic Cytogenetics Reference Sheet, November 2012